Company intelligence / Profile preview
Dr. Pandalis
- Ownership
- Private
- Employees
- ~4
- Development stage
- Other
Overview
Dr. Pandalis is a privately held German natural-products and healthcare company group focused on research, development, manufacturing, and commercialization of plant-based medicinal products, dietary supplements, cosmetics, and foods. The group comprises Naturprodukte Dr. Pandalis GmbH & Co. KG, which develops nutritional supplements, cosmetics, and food products, and Dr. Pandalis Urheimische Medizin GmbH & Co. KG, which develops medicinal products and drugs. Its portfolio centers on traditional European plants and includes branded commercial products such as Cystus Pandalis lozenges, Lefteria, Cystus teas and extracts, Salicornia iodine tablets, and other consumer health products. The business appears to be revenue-generating and commercially active rather than a venture-stage biotech with a conventional clinical pipeline. It is best characterized as a natural medicines and consumer healthcare company with in-house product development and manufacturing in Germany.
- Therapeutic areas
- CardiovascularDermatologyPulmonologyGastroenterologyMetabolic Disorders
- Modalities
- Small moleculeBiologicNon-pharmacological therapy
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Dr. Pandalis.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dr. Pandalis.